• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆金属蛋白酶组织抑制剂-1生物学变异的评估

Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.

作者信息

Frederiksen C B, Lomholt A F, Lottenburger T, Davis G J, Dowell B L, Blankenstein M A, Christensen I J, Brunner N, Nielsen H J

机构信息

Department of Surgical Gastroenterology, Hvidovre University Hospital, Hvidovre - Denmark.

出版信息

Int J Biol Markers. 2008 Jan-Mar;23(1):42-7. doi: 10.1177/172460080802300107.

DOI:10.1177/172460080802300107
PMID:18409150
Abstract

BACKGROUND

Tissue inhibitor of metalloproteinases-1 (TIMP-1) measurements in plasma may be useful for the early detection and prognosis of colorectal cancer (CRC). Data on analytical performance and normal intra- and interindividual biological variation are required in order to interpret the utility of TIMP-1 in CRC. The aim of this study was to establish the biological and analytical variation of plasma TIMP-1 in volunteers.

MATERIAL AND METHODS

Three separate studies were undertaken. 1: Plasma was collected from 23 volunteers 6 times within a 3-week period, first in September 2004 (round [R] 1), then repeated in May 2005 (R2) and May 2006 (R3) in the same group of individuals. TIMP-1 levels were determined by the MAC15 ELISA assay and with the Abbott ARCHITECT i2000 Immunoanalyzer. 2: Circadian variation was evaluated in plasma collected 7 times within a 24-hour period (n=16). 3: Effects of physical exercise were evaluated in plasma collected before and after bicycling (n=14). In studies 2 and 3 TIMP-1 levels were determined with the MAC15 ELISA assay only.

RESULTS

A significant correlation between TIMP-1 MAC15 and ARCHITECT i2000 was shown (rs=0.78, p<0.002), with consistently higher levels being detected by the ARCHITECT i2000. Median levels of TIMP-1 (ARCHITECT) at 8 a.m. in each round were 74.9 ng/mL (range 65.7-89.9) (R1), 87.3 ng/mL (range 72.7-127.9) (R2), and 81.9 ng/mL (range 66.8-113.6) (R3). The within-subject variation was 10.7%, the variation between rounds was 7.4%, and the intraclass correlation was 46.2%. Comparison between the 3 rounds and time of collection showed that TIMP-1 values decreased by 11% after storage for more than 16 months (p=0.0002). A systematic circadian variation in plasma TIMP-1 levels was not observed (p=0.17). No significant variation of plasma TIMP-1 was found in relation to physical exercise (p=0.92 [global test]).

CONCLUSION

Levels of plasma TIMP-1 in volunteers show limited circadian, day-to-day, week-to-week and season-to-season variation. In addition, physical exercise has no impact on plasma TIMP-1 levels. Possible storage-dependent decreases in plasma TIMP-1 levels warrant further investigation.

摘要

背景

血浆中金属蛋白酶组织抑制剂-1(TIMP-1)的检测可能有助于结直肠癌(CRC)的早期诊断和预后评估。为了解TIMP-1在CRC中的应用价值,需要有关分析性能以及个体内和个体间正常生物学变异的数据。本研究的目的是确定志愿者血浆中TIMP-1的生物学和分析变异。

材料与方法

进行了三项独立研究。1:在3周内从23名志愿者身上采集6次血浆,首次采集于2004年9月(第1轮[R]),然后于2005年5月(R2)和2006年5月(R3)在同一组个体中重复采集。TIMP-1水平通过MAC15 ELISA检测法和雅培ARCHITECT i2000免疫分析仪测定。2:在24小时内采集7次血浆(n = 16),评估昼夜变化。3:在骑自行车前后采集血浆(n = 14),评估体育锻炼的影响。在研究2和3中,仅通过MAC15 ELISA检测法测定TIMP-1水平。

结果

TIMP-1 MAC15与ARCHITECT i2000之间显示出显著相关性(rs = 0.78,p < 0.002),ARCHITECT i2000检测到的水平始终较高。每一轮上午8点时TIMP-1(ARCHITECT)的中位数水平分别为74.9 ng/mL(范围65.7 - 89.9)(R1)、87.3 ng/mL(范围72.7 - 127.9)(R2)和81.9 ng/mL(范围66.8 - 113.6)(R3)。受试者内变异为10.7%,轮次间变异为7.4%,组内相关系数为46.2%。三轮检测结果与采集时间的比较表明,储存超过16个月后TIMP-1值下降了11%(p = 0.0002)。未观察到血浆TIMP-1水平有系统性的昼夜变化(p = 0.17)。未发现血浆TIMP-1水平与体育锻炼有显著相关性(p = 0.92[整体检验])。

结论

志愿者血浆中TIMP-1水平在昼夜、每日、每周和季节之间的变化有限。此外,体育锻炼对血浆TIMP-1水平没有影响。血浆TIMP-1水平可能存在的储存依赖性下降值得进一步研究。

相似文献

1
Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1.血浆金属蛋白酶组织抑制剂-1生物学变异的评估
Int J Biol Markers. 2008 Jan-Mar;23(1):42-7. doi: 10.1177/172460080802300107.
2
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.原发性结直肠癌患者血浆、血清及肿瘤组织提取物中金属蛋白酶组织抑制剂-1的比较研究。
Scand J Gastroenterol. 2008;43(2):186-91. doi: 10.1080/00365520701491355.
3
Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.原发性结直肠癌切除术后血浆组织金属蛋白酶抑制因子-1水平的变化
Anticancer Res. 2009 Jan;29(1):75-81.
4
Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.通过表面增强激光解吸/电离飞行时间质谱法对结直肠癌患者和献血者血浆中的金属蛋白酶组织抑制剂1进行研究。
Int J Biol Markers. 2007 Apr-Jun;22(2):89-94. doi: 10.1177/172460080702200201.
5
Tissue inhibitor of metalloproteinases-1 as a biological marker in colorectal cancer: influence of smoking on plasma levels?组织金属蛋白酶抑制剂-1 作为结直肠癌的生物学标志物:吸烟对血浆水平的影响?
Int J Biol Markers. 2013 Jun 28;28(2):226-30. doi: 10.5301/jbm.5000017.
6
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases 1 in plasma by immunoassay.
Clin Chem. 2002 Aug;48(8):1305-13.
7
Plasma TIMP-1 and CEA in detection of primary colorectal cancer: a prospective, population based study of 4509 high-risk individuals.血浆组织金属蛋白酶抑制因子-1和癌胚抗原在原发性结直肠癌检测中的应用:一项针对4509名高危个体的基于人群的前瞻性研究。
Scand J Gastroenterol. 2011 Jan;46(1):60-9. doi: 10.3109/00365521.2010.513060. Epub 2010 Aug 30.
8
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.术前血浆金属蛋白酶组织抑制因子-1水平高与结直肠癌患者的生存期短相关。
Clin Cancer Res. 2000 Nov;6(11):4292-9.
9
Plasma TIMP-1 and CEA as Markers for Detection of Primary Colorectal Cancer: A Prospective Validation Study Including Symptomatic and Non-symptomatic Individuals.血浆组织金属蛋白酶抑制因子-1和癌胚抗原作为原发性结直肠癌检测标志物的前瞻性验证研究:一项纳入有症状和无症状个体的研究
Anticancer Res. 2015 Sep;35(9):4935-41.
10
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.术前血清基质金属蛋白酶(MMP - 2、MMP - 9)及基质金属蛋白酶组织抑制剂(TIMP - 1、TIMP - 2)分析在结直肠癌中的价值有限。
Anticancer Res. 2000 Mar-Apr;20(2B):1085-91.

引用本文的文献

1
Development of blood-based biomarker tests for early detection of colorectal neoplasia: Influence of blood collection timing and handling procedures.用于结直肠肿瘤早期检测的基于血液的生物标志物检测的开发:血液采集时间和处理程序的影响。
Clin Chim Acta. 2020 Aug;507:39-53. doi: 10.1016/j.cca.2020.03.035. Epub 2020 Apr 6.
2
Biological variation of extracellular matrix biomarkers in patients with stable chronic heart failure.稳定型慢性心力衰竭患者细胞外基质生物标志物的生物学变异。
Clin Res Cardiol. 2017 Dec;106(12):974-985. doi: 10.1007/s00392-017-1147-5. Epub 2017 Aug 4.
3
Circadian Rhythm of Methylated Septin 9, Cell-Free DNA Amount and Tumor Markers in Colorectal Cancer Patients.
结直肠癌患者甲基化丝聚蛋白9、游离DNA含量及肿瘤标志物的昼夜节律
Pathol Oncol Res. 2017 Jul;23(3):699-706. doi: 10.1007/s12253-016-0174-2. Epub 2016 Dec 30.
4
Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.胶质母细胞瘤患者中TIMP-1免疫组化、TIMP-1荧光原位杂交分析及血浆TIMP-1的比较研究。
J Neurooncol. 2016 Dec;130(3):439-448. doi: 10.1007/s11060-016-2252-4. Epub 2016 Sep 12.
5
Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer.正电子发射断层扫描/计算机断层扫描与生物标志物在转移性结直肠癌的早期治疗反应评估中的应用。
Oncologist. 2014 Feb;19(2):164-72. doi: 10.1634/theoncologist.2013-0229. Epub 2014 Jan 22.
6
The correlation between the levels of tissue inhibitor of metalloproteinases 1 in plasma and tumour response and survival after preoperative radiochemotherapy in patients with rectal cancer.术前放化疗后直肠癌患者血浆组织金属蛋白酶抑制剂 1 水平与肿瘤反应和生存的相关性。
Radiol Oncol. 2013 May 21;47(2):138-44. doi: 10.2478/raon-2013-0028. Print 2013 Jun.
7
Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III.健康人与 II 期或 III 期直肠癌患者血浆 TIMP-1 水平的差异。
Radiol Oncol. 2011 Sep;45(3):209-12. doi: 10.2478/v10019-011-0027-2. Epub 2011 Aug 26.
8
Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview.血清生物标志物用于提高胰腺癌的诊断:当前概述。
J Cancer Res Clin Oncol. 2011 Mar;137(3):375-89. doi: 10.1007/s00432-010-0965-x. Epub 2010 Dec 31.
9
Banking of biological fluids for studies of disease-associated protein biomarkers.储存生物流体用于疾病相关蛋白质生物标志物的研究。
Mol Cell Proteomics. 2008 Oct;7(10):2061-6. doi: 10.1074/mcp.R800010-MCP200. Epub 2008 Aug 1.